Form 4: ALHC CHRO Sells Shares for Tax, 10b5-1 Plan

Alignment Healthcare's Chief Human Resources Officer, Andreas P. Wagner, sold shares to cover tax obligations and under a pre-arranged 10b5-1 plan.

Summary

• Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare, Inc. (ALHC), reported two sales of common stock.
• On March 18, 2026, 12,000 shares were sold at a weighted-average price of $17.84 per share to cover tax withholding obligations related to restricted stock unit vesting. This was not a discretionary trade.
• On March 19, 2026, an additional 11,602 shares were sold at a weighted-average price of $18.2207 per share, executed under a Rule 10b5-1 trading plan adopted on November 21, 2025.
• Following these transactions, Wagner directly beneficially owns 148,628 shares of Alignment Healthcare common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. The sales are primarily for tax obligations and a pre-scheduled 10b5-1 plan, which are common and generally not indicative of a change in the executive's confidence in the company's future.

Positives

• The sale to cover tax withholding is a non-discretionary event, indicating it's a standard part of RSU vesting rather than a voluntary divestment based on negative sentiment.
• The second sale was executed under a pre-arranged Rule 10b5-1 plan, which suggests a planned liquidity event rather than an immediate reaction to company performance.

Negatives

• A significant reduction in direct beneficial ownership by a key executive, totaling 23,602 shares, could be perceived negatively by some investors, even if planned.
• The sales occurred at prices ranging from $17.40 to $18.30, which might be seen as an executive taking profits.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly those related to tax obligations or pre-scheduled 10b5-1 plans, are common occurrences in the healthcare services industry. While they represent a reduction in executive ownership, they do not inherently signal a change in company fundamentals or management's long-term outlook, unlike discretionary open-market sales.

Stakeholder Impact

• Shareholders: May view the reduction in executive ownership with slight caution, though the reasons (tax, 10b5-1 plan) mitigate concerns.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Recommendation

The reported transactions are routine insider sales for tax obligations and a pre-scheduled 10b5-1 plan, rather than discretionary sales based on new information. As such, they do not provide a strong signal for a change in the company's fundamental outlook or warrant a change in investment thesis. Investors should hold and monitor future company performance and broader market trends.

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Executive Compensation, Restricted Stock Units, RSU, 10b5-1 Plan, Andreas P. Wagner